Aller au contenu
Aperlena
Langue:

Finland - Medical equipments, pharmaceuticals and personal care products - Methylation tests

Attribué Avis d'attribution Aucune date limite publiée
Suivre ce marché

Les offres sont closes. Une attribution ou un rectificatif sur cet avis : un e-mail quand le registre le voit. Se connecter

  1. Attribué
  2. Publié

Description

The HUS Group requested tenders for MGMT and MLH1 methylation tests. The procurement includes the following products: - MGMT and MLH1 methylation tests. The procurement is divided into two (2) product groups, which are: Product group 1: MGMT methylation tests Product group 2: MLH1 promotor methylation tests The supplier could bid on one or both sections of the procurement. The estimated number of MGMT methylation tests per year is around 200. The estimated number of MLH1 promotor methylation tests per year would be around 80. The products were described in more detail in invitation to tender and in Appendix 2 to the invitation to tender (Price and product form). In each subarea the most economically advantageous tender shall be selected. The criterion for determining the most economically advantageous tender shall be the best price-quality ratio. Price is weighted at 80 % and quality is weighted at 20 %. The comparison criteria for subareas 1-2, how to perform the comparison, and the related calculation formulas are described in more detail in the "General criteria of the sub-area" section of each subarea. HUS will select for each area two (2) contract suppliers in the ranking order of the tenderers. More information about the order of priority and its formation can be found in the section "Grounds for decision". The goal of this competitive procurement was to get products that are safe to use. The goal was also to have good product delivery reliability and to have products available when they are needed. During the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the Appendix 2 Product and price form (please see Agreement). The Agreement is in force for a fixed period of 3 years, and thereafter until terminated. The aim is to bring the agreement into force as soon as possible after the procurement procedure has been completed. The estimated starting day for the contract period is 3.11.2025 The products requested in this invitation to tender will be used by the Genetics Laboratory of the HUS Diagnostic Centre (Helsinki University Hospital, HUS Group). See Annex 1 (Agreement) of the call for tenders for details. The total estimated value of the procurement (VAT 0%) is approximately EUR 620 000 for 48 months. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes. The products are described in more detail in invitation to tender and in Appendix 2 to the invitation to tender (Price and product form).

Source officielle

Source : TED - Tenders Electronic Daily (Publications Office of the EU)

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de TED - Tenders Electronic Daily (Publications Office of the EU) il y a 1 mois

Consulter l'avis officiel

Plus de cet acheteur

Profil complet de l'acheteur

1 marché ouvert actuellement

Attributions récentes

Historique des modifications

Chaque republication de cet avis par une source officielle avec un contenu différent. Nous surveillons toutes les sources que nous indexons, y compris les copies régionales du même avis.

  1. A lire avant de repondre
    • Objet et critères: La description a été étoffée. À relire avant de repondre.

Suivez ce marche et nous vous ecrivons dès qu'il change. Créer un compte

Marchés similaires

6

jours restants

Rideaux antimicrobiens

Finlande Équipements médicaux & produits pharmaceutiques Päijät-Hämeen hyvinvointialue

Contexte de marché

Appel ouvert moyen · Équipements médicaux & produits pharmaceutiques
10 028 743 €
9 662 ouverts en Europe actuellement
Historique de l'acheteur sur Aperlena
29 avis suivis · 8 attribués
4 129 470 € de contrats attribués

Ne manquez plus aucun marché comme celui-ci

39 nouveaux avis pour Équipements médicaux & produits pharmaceutiques en Finlande au cours des 7 derniers jours. Recevez un e-mail quand de nouveaux avis paraissent. Gratuit.

Créer mon alerte
Source

Raccourcis clavier

Parcourir une liste sans toucher la souris. Les raccourcis restent inactifs pendant la saisie dans un champ.

j
Résultat suivant
k
Résultat précédent
Entrée
Ouvrir le résultat
n
Page suivante
p
Page précédente
c
Comparer ce résultat
s
Ajouter ce résultat à la présélection
/
Aller au champ de recherche
?
Afficher ces raccourcis
Échap
Fermer